These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23639535)

  • 1. Modular, efficient synthesis of asymmetrically substituted piperazine scaffolds as potent calcium channel blockers.
    Borzenko A; Pajouhesh H; Morrison JL; Tringham E; Snutch TP; Schafer LL
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3257-61. PubMed ID: 23639535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers.
    Park JE; Ji WK; Jang JW; Pae AN; Choi K; Choi KH; Kang J; Roh EJ
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1887-90. PubMed ID: 23395659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
    Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
    Lee HK; Lee YS; Roh EJ; Rhim H; Lee JY; Shin KJ
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4424-7. PubMed ID: 18625556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Zhang L; Pajouhesh H; Jiang X; Hendricson A; Dong H; Tringham E; Ding Y; Vanderah TW; Porreca F; Belardetti F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4153-8. PubMed ID: 22579422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity.
    Beebe X; Darczak D; Henry RF; Vortherms T; Janis R; Namovic M; Donnelly-Roberts D; Kage KL; Surowy C; Milicic I; Niforatos W; Swensen A; Marsh KC; Wetter JM; Franklin P; Baker S; Zhong C; Simler G; Gomez E; Boyce-Rustay JM; Zhu CZ; Stewart AO; Jarvis MF; Scott VE
    Bioorg Med Chem; 2012 Jul; 20(13):4128-39. PubMed ID: 22626552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers.
    Choi YH; Baek du J; Seo SH; Lee JK; Pae AN; Cho YS; Min SJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):215-9. PubMed ID: 21126876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers.
    Mehanna AS; Kim JY
    Bioorg Med Chem; 2005 Jul; 13(13):4323-31. PubMed ID: 15927838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of diphenyl lactam derivatives as N-type calcium channel blockers.
    Doherty GA; Bhatia P; Vortherms TA; Marsh KC; Wetter JM; Mack H; Scott VE; Jarvis MF; Stewart AO
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1716-8. PubMed ID: 22277280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and evaluation of selective N-type calcium channel blockers: 6-unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives.
    Yamamoto T; Niwa S; Tokumasu M; Onishi T; Ohno S; Hagihara M; Koganei H; Fujita S; Takeda T; Saitou Y; Iwayama S; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3639-42. PubMed ID: 22560585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.
    Ogiyama T; Inoue M; Honda S; Yamada H; Watanabe T; Gotoh T; Kiso T; Koakutsu A; Kakimoto S; Shishikura J
    Bioorg Med Chem; 2014 Dec; 22(24):6899-907. PubMed ID: 25456079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channels.
    Sairaman A; Cardoso FC; Bispat A; Lewis RJ; Duggan PJ; Tuck KL
    Bioorg Med Chem; 2018 Jul; 26(11):3046-3059. PubMed ID: 29622412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity study of L-amino acid-based N-type calcium channel blockers.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem; 2003 Apr; 11(8):1901-13. PubMed ID: 12659776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.
    Yamamoto T; Niwa S; Ohno S; Tokumasu M; Masuzawa Y; Nakanishi C; Nakajo A; Onishi T; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4813-6. PubMed ID: 18684623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain.
    Beebe X; Yeung CM; Darczak D; Shekhar S; Vortherms TA; Miller L; Milicic I; Swensen AM; Zhu CZ; Banfor P; Wetter JM; Marsh KC; Jarvis MF; Scott VE; Schrimpf MR; Lee CH
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4857-61. PubMed ID: 23876987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead discovery and optimization of T-type calcium channel blockers.
    Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
    Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.